Daniella Pettersson
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Assessment of potential nephrotoxicity biomarkers after [177Lu]Lu-DOTA-(Tyr3)-octreotate administration and effects of antioxidant α1-microglobulin.
Journal: Scientific reports
Published: January 22, 2026
Late apoptotic effects after treatment with 177Lu-octreotate in small-intestine neuroendocrine GOT1 tumor model.
Journal: International journal of radiation biology
Published: August 12, 2025
Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotide.
Journal: Radiation protection dosimetry
Published: June 24, 2024
Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer.
Journal: Molecular therapy. Oncology
Published: December 14, 2023
Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer.
Journal: Cell death discovery
Published: June 04, 2023
Trefoil factor family proteins as potential diagnostic markers for mucinous invasive ovarian carcinoma.
Journal: Frontiers in oncology
Published: November 30, 2022
Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer types.
Journal: BMC cancer
Published: January 14, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026